We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current VIR market cap is 1.42B. The company's latest EPS is USD -4.5549 and P/E is -2.31.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 62.96M | 3.8M | 2.64M | 16.79M | 56.38M |
| Operating Income | -143.37M | -215.19M | -186.73M | -131.32M | -80.08M |
| Net Income | -140.9M | -194.78M | -163.41M | -115.97M | -65.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8.09M | 76.37M | 1.1B | 1.62B | 86.18M |
| Operating Income | -177.98M | -296.98M | 420.75M | 833.07M | -676.61M |
| Net Income | -174.68M | -298.67M | 528.58M | 515.84M | -615.06M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.67B | 2.24B | 2.04B | 1.92B | 1.79B |
| Total Liabilities | 695.14M | 433.67M | 369.81M | 328.82M | 246.61M |
| Total Equity | 1.97B | 1.81B | 1.68B | 1.59B | 1.55B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 512.07M | 918.76M | 1.95B | 2.8B | 1.92B |
| Total Liabilities | 88.13M | 201.91M | 522.42M | 724.13M | 328.82M |
| Total Equity | 423.94M | 716.85M | 1.43B | 2.08B | 1.59B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -125.78M | -515.03M | -670.86M | -778.79M | -109.39M |
| Investing | 98.08M | 328.39M | 269.44M | 164.63M | 28.42M |
| Financing | 2.34M | 5.52M | 5.8M | 7.48M | 152k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -129.63M | -190.94M | -47.59M | 1.66B | -778.79M |
| Investing | -256.16M | -9.86M | -140.81M | -1.19B | 164.63M |
| Financing | 449.24M | 529.47M | 100.33M | 34.76M | 7.48M |
| Market Cap | 1.42B |
| Price to Earnings Ratio | -2.31 |
| Price to Sales Ratio | 16.52 |
| Price to Cash Ratio | 5.89 |
| Price to Book Ratio | 0.89 |
| Dividend Yield | - |
| Shares Outstanding | 135.03M |
| Average Volume (1 week) | 917.23k |
| Average Volume (1 Month) | 955.19k |
| 52 Week Change | -60.55% |
| 52 Week High | 27.48 |
| 52 Week Low | 7.61 |
| Spread (Intraday) | 0.2 (1.9%) |
| Company Name | Vir Biotechnology Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.vir.bio |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
